Tag: mushrooms
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
Shroom stocks go nuts: First movers SHRM, MMED, RVV up hard as gamblers gamble
Today was a day that daytraders have been looking forward to for some time; the day that shroom stocks finally gripped the road and took off. Mind Medicine (MMED.E) ripped 90% to $0.77 on the back of 15m shares traded, reminding anyone who’d listen that ex-Canopy CEO Bruce Linton and pretend billionaire Kevin O’Leary were on…
-
![Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more….]()
Equity.Guru podcast: pt. 2 Yield Growth (BOSS.C) CEO Penny White talks about Urban Juve, topicals, mushrooms and more….
In this, part 2 of a two-part interview, Penny White, CEO of Yield Growth, spoke with Equity.Guru’s Guy Bennett about the target market for Urban Juve, branding, packaging, South America, regulation, topicals, Wright & Well, mushrooms and the potential end game.
-
![OK boomer: In which I come to Jesus over mushrooms and put my dollars into Absolem]()
OK boomer: In which I come to Jesus over mushrooms and put my dollars into Absolem
50 years I’ve been bumbling around this planet, and the best damn weekend I’ve had on it to date occurred recently, under the influence of mushrooms. The carpet didn’t talk to me and the walls weren’t bleeding, and the sunrise wasn’t the incarnation of Shiva. That ain’t it, kids. No, what happened is my head…
